AU7438694A - 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine - Google Patents

1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine

Info

Publication number
AU7438694A
AU7438694A AU74386/94A AU7438694A AU7438694A AU 7438694 A AU7438694 A AU 7438694A AU 74386/94 A AU74386/94 A AU 74386/94A AU 7438694 A AU7438694 A AU 7438694A AU 7438694 A AU7438694 A AU 7438694A
Authority
AU
Australia
Prior art keywords
sulfonylaminomethyl
dihydro
oxo
pyridine
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74386/94A
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU7438694A publication Critical patent/AU7438694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
AU74386/94A 1993-10-08 1994-09-30 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine Abandoned AU7438694A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4334308 1993-10-08
DE4334308A DE4334308A1 (en) 1993-10-08 1993-10-08 1,2-dihydro-2-oxo-3-pyridine-methylsulfonylaminomethyl

Publications (1)

Publication Number Publication Date
AU7438694A true AU7438694A (en) 1995-04-27

Family

ID=6499685

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74386/94A Abandoned AU7438694A (en) 1993-10-08 1994-09-30 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine

Country Status (14)

Country Link
EP (1) EP0647627A1 (en)
JP (1) JPH07188171A (en)
KR (1) KR950011410A (en)
CN (1) CN1106387A (en)
AU (1) AU7438694A (en)
CA (1) CA2133804A1 (en)
CZ (1) CZ240194A3 (en)
DE (1) DE4334308A1 (en)
HU (1) HUT70555A (en)
NO (1) NO943791L (en)
PL (1) PL305354A1 (en)
RU (1) RU94036750A (en)
SK (1) SK121494A3 (en)
ZA (1) ZA947884B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4336051A1 (en) * 1993-10-22 1995-04-27 Merck Patent Gmbh 1,2-Dihydro-2-oxopyridines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4129340A1 (en) * 1991-09-04 1993-03-11 Merck Patent Gmbh 1,2-dihydro-2-OXOPYRIDINE

Also Published As

Publication number Publication date
JPH07188171A (en) 1995-07-25
SK121494A3 (en) 1995-05-10
HU9402902D0 (en) 1995-02-28
NO943791D0 (en) 1994-10-07
PL305354A1 (en) 1995-04-18
HUT70555A (en) 1995-10-30
CN1106387A (en) 1995-08-09
DE4334308A1 (en) 1995-04-13
ZA947884B (en) 1995-05-22
CA2133804A1 (en) 1995-04-09
NO943791L (en) 1995-04-10
CZ240194A3 (en) 1995-04-12
RU94036750A (en) 1996-09-10
EP0647627A1 (en) 1995-04-12
KR950011410A (en) 1995-05-15

Similar Documents

Publication Publication Date Title
DE59403259D1 (en) Tetraaroxyperylen-3,4,9,10-tetracarbonsäurepolyimide
AU660321B2 (en) 1,2-dihydro-2-oxopyridine
AU7583794A (en) 1-amino-ethylindole-derivatives
AU6001594A (en) Imidazoazines
AU6710294A (en) Tetrahydro-beta-carbolines
AU7138394A (en) N,n-diacylpiperazines
AU6705294A (en) Tetrahydro-pyrido-indole
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
ZA946569B (en) 1,5-Diphenyl-3-pyrazolylalkyl-N-hydroxydithiocarbamates
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
AU1274295A (en) Heteroarylpyrroles
AU6389494A (en) Tv-projector
AU8104694A (en) Bagbottle
AU5922894A (en) 2,6-Disubstituted 4-quinolyl-dihydropyridines
AU6971594A (en) Cyclobutylazoles
AU6427194A (en) Aza-androstane-17beta -carboxamides
AU2137095A (en) Heterocyclyl-1,3,4-thiadiazolyloxyacetamides
AU7593294A (en) 1,2-dihydro-2-oxo-pyridine
AU7285994A (en) Suncap
AU5780894A (en) Crankhead
AU3696093A (en) Aquamate
AU7194594A (en) 7alpha-amino-1,1-dioxocefem l-valylamides
AU7438694A (en) 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine
AU5830994A (en) Zusammenklappbares baukastensystem